Results 151 to 160 of about 202,497 (309)
Objective Tofersen is the first effective and approved therapy for superoxide dismutase 1 (SOD1)‐associated amyotrophic lateral sclerosis (ALS [SOD1‐ALS]). Following treatment with tofersen, neurofilament levels in patients' cerebrospinal fluid (CSF) and serum seem to respond earlier than clinical parameters.
Christina Steffke +36 more
wiley +1 more source
Oculomotor Palsy after Flow Diverter Treatment for Paraclinoid Aneurysm: Case Report and Literature Review. [PDF]
Higaki A, Namba K.
europepmc +1 more source
This study demonstrates that intranasal Wharton's jelly‐derived mesenchymal stem cell (WJ‐MSC) administration at 3 or 10 days post‐insult reduced the lesion size and sensorimotor impairment following neonatal hypoxic‐ischemic (HI) brain injury in mice. WJ‐MSCs expressed receptors for HI‐upregulated chemokines and migrated from the nasal cavity into the
Caroline G. M. de Theije +9 more
wiley +1 more source
Cavernous Sinus Arteriovenous Fistula Presenting as Acute Third Nerve Palsy With Coexisting Sphenoid Sinusitis. [PDF]
Chiang KC, Lee CW, Xiao FR, Lin CF.
europepmc +1 more source
Happy 75th National Institute of Neurological Disorders and Stroke
For 75 years the National Institute of Neurological Disorders and Stroke has led neurological research in the US. Many thousands of people have volunteered in research and thousands of investigators devoted their careers to pursuing better treatments of neurological disorders.
Walter J. Koroshetz
wiley +1 more source
Bilateral Vertical Gaze Paralysis With Collier's Sign and Contralesional Pseudo-Abducens Paresis From Unilateral Dorsomedial Thalamic Stroke. [PDF]
Hernandez Silva Y +4 more
europepmc +1 more source
A CASE OF ETHMOIDAL INJURY ASSOCIATED WITH PAPILLOEDEMA, ABDUCENS PALSY, AND OTHER OCULAR LESIONS [PDF]
F. W. Watkyn-Thomas, R. L. Scott
openalex +1 more source

